首页|机器人辅助腹腔镜全体腔内与体外原位新膀胱的对照研究

机器人辅助腹腔镜全体腔内与体外原位新膀胱的对照研究

扫码查看
目的 比较机器人辅助腹腔镜根治性膀胱切除术(RARC)中行全体腔内原位新膀胱(ICNB)与体外原位新膀胱(ECNB)的围手术期效果和术后并发症.方法 回顾性分析2017年1月至2022年6月陆军军医大学第一附属医院行RARC+原位新膀胱的265例患者的病例资料,其中ECNB组107例,ICNB组158例.使用倾向性评分匹配法,根据性别、年龄、体质量指数(BMI)、美国麻醉医师协会(ASA)分级、新辅助化疗(NAC)、腹部手术史和肿瘤特征对两组进行1∶1匹配.本研究中共186例患者配对,每组各93例.ICNB组男91例,女2例;中位年龄64(55,68)岁;BMI为23.54(22.39,25.39)kg/m2;临床分期≤T2期 91 例;NAC 25 例;ASA 分级≥ Ⅲ级 15 例.ECNB 组男 91 例,女 2 例;中位年龄 63(52,67)岁;BMI 为 23.31(20.76,24.80)kg/m2;临床分期 ≤T2期 90 例;NAC 12例;ASA分级≥ Ⅲ级8例.ECNB组在完成RARC和盆腔淋巴结清扫后,采用传统的下腹部切口,将肠管牵拉至体外完成新膀胱制备后再还纳至盆腔吻合.ICNB组由机器人辅助下在体腔内完成原位新膀胱的重建.比较两组的手术时间、术中出血量、围手术期并发症等的差异.结果 ICNB组和ECNB组的中位手术时间分别为302(261,350)min和337(285,397)min(P=0.003),中位术中出血量分别为 300(225,500)ml 和 500(300,650)ml(P<0.01),围术期输血率分别为 4.3%(4/93)和14.0%(13/93)(P=0.022),差异均有统计学意义.术后90 d内ICNB组总并发症发生率低于ECNB组[38.7%(36/93)与61.3%(57/93),P=0.002].术后90 d内两组严重并发症发生率差异无统计学意义[8.6%(8/93)与16.1%(15/93),P=0.119].多因素logistics回归分析结果显示,与术后90 d内总并发症相关的因素是手术时间(OR=1.004,95%CI 1.000~1.007,P=0.040),手术方式(OR=2.248,95%CI 1.220~4.141,P=0.009),年龄(OR=1.036,95%CI 1.002~1.072,P=0.037);与术后90 d内严重并发症相关的因素是手术时间(OR=1.008,95%CI 1.004~1.013,P<0.01)、新辅助化疗(OR=0.198,95%CI0.059~0.663,P=0.009)和 ASA 分级(OR=0.167,95%CI 0.044~0.634,P=0.009).结论 在RARC术中,ICNB技术是安全可行的.与体外重建相比,ICNB可以缩短手术时间,减少出血,降低术后并发症发生率.
Propensity matching study of robot-assisted intracorporeal versus extracorporeal orthotopic neobladder reconstruction
Objective To compare the surgical efficacy and perioperative complications of total intracorporeal neobladder(ICNB)and extracorporeal neobladder(ECNB)reconstruction during robot-assisted radical cystectomy.Methods We retrospectively reviewed our single-institutional,prospectively collected database for consecutive patients who underwent RARC with an ileum neobladder from January 2017 to June 2022.A total of 265 patients were collected,158 in ICNB group and 107 in ECNB group.The two groups were matched 1∶1 according to gender,age,BMI,ASA score,NAC,history of abdominal surgery and tumor characteristics using propensity score matching(PSM)method.After PSM,operating time,estimated blood loss and perioperative complications were compared between ICNB and ECNB group.A total of 186 patients were paired(93 patients in each group).There were 91 males and 2 females in ICNB group.The median age of ICNB group was 64(55,68)years;median BMI was 23.54(22.39,25.39)kg/m2;There were 91 cases with Clinical stage ≤T2 stage and 15 cases with ASA score ≥3;25 cases received neoadjuvant chemotherapy.There were 91 males and 2 females in ECNB group.The median age of ECNB group was 63(52,67)years;median BMI was 23.31(20.76,24.80)kg/m2;There were 90 cases with Clinical stage ≤T2 stage and 8 cases with ASA score ≥3;12 cases received neoadjuvant chemotherapy.In the ECNB group,after completing the radical cystectomy and pelvic lymph node dissection with robot assistance,the traditional lower abdominal incision was used to pull the intestinal tube outside the body to complete the preparation of the new bladder and then restore it to the pelvic cavity for anastomosing,while in the ICNB group,the reconstruction of the new bladder in situ was always completed in the body cavity with robot assistance.The operative time,intraoperative blood loss and perioperative complications were compared between the two groups.Results The median operative time in ICNB and ECNB groups was 302(261,350)min and 337(285,397)min,respectively(P=0.003);median intraoperative blood loss was 300(225,500)ml and 500(300,650)ml,respectively(P<0.01);perioperative blood transfusion rates were 4.3%(4/93)and 14.0%(13/93),respectively(P=0.022);all the differences between the 2 groups were statistically significant.90-d overall complications rate was significant lower in ICNB group(38.7%vs.61.3%,P=0.002).There was no difference in 90-d major complications(8.6%vs.16.1%,P=0.119).On multivariate logistic regression analysis,operating time(OR=1.004,95%CI 1.000-1.007,P=0.040),surgical approach(ICNB/ECNB)(OR=2.248,95%CI 1.220-4.141,P=0.009)and age(OR=1.036,95%CI 1.002-1.072,P=0.037)were associated with 90-day overall complications.Operating time(OR=1.036,95%CI 1.002-1.072,P=0.037),neoadjuvant chemotherapy(OR=0.198,95%CI 0.059-0.663,P=0.009)and ASA score(OR=0.167,95%CI 0.044-0.634,P=0.009)were associated with 90-day high-grade complications.Conclusion Intracorporeal neobladder during robot-assisted radical cystectomy is safe and feasible.Compared with ECNB,ICNB significantly improved perioperative outcomes such as shorter operating time,fewer estimated blood loss and perioperative complications.

Urinary bladder neoplasmsRobotUrinary diversionOrthotopic neobladderIntracorporeal

闫兵、刘苑、周晓洲、刘洋、李雨威、李雪梅、陈志文

展开 >

陆军军医大学第一附属医院泌尿外科 全军泌尿外科研究所,重庆 400038

膀胱肿瘤 机器人 尿流改道 原位新膀胱 全体腔内

2024

中华泌尿外科杂志
中华医学会

中华泌尿外科杂志

CSTPCD北大核心
影响因子:1.628
ISSN:1000-6702
年,卷(期):2024.45(12)